National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 351587

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

VAERS ID: 351587
VAERS Form:
Age:17.0
Gender:Female
Location:Foreign
Vaccinated:2009-03-23
Onset:2009-04-10
Submitted:2009-07-16
Entered:2009-07-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (PRIORIX) / GLAXOSMITHKLINE BIOLOGICALS - / - LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Pregnancy on oral contraceptive, Drug exposure during pregnancy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0583179A

Write-up: This case was reported by a foreign regulatory authority (# 2009-02622) and described the occurrence of pregnancy on oral contraceptive in a 17-year-old female subject who was vaccinated with PRIORIX (GlaxoSmithKline), ENGERIX B adult and GARDASIL (non-GSK). Since April 2008, the subject was under YASMIN without forgetting to take the pill, without co-medication or episode of diarrhea or vomiting. On 23 March 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). On 27 March 2009, the subject had her last menstruation. On 30 March 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 10 April 2009 (estimated date of conception for a regular cycle), the subject was found to be pregnant. On 28 May 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 8 June 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). The regulatory authority reported that the events were clinically significant (or requiring intervention). The regulatory authority reported that the events were possibly related to vaccination with PRIORIX, ENGERIX B adult and GARDASIL and to YASMIN.


Changed on 9/14/2017

VAERS ID: 351587 Before After
VAERS Form:(blank) 1
Age:17.0
Gender:Female
Location:Foreign
Vaccinated:2009-03-23
Onset:2009-04-10
Submitted:2009-07-16
Entered:2009-07-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (PRIORIX) / GLAXOSMITHKLINE BIOLOGICALS - / - UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Pregnancy on oral contraceptive, Drug exposure during pregnancy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0583179A

Write-up: This case was reported by a foreign regulatory authority (# 2009-02622) and described the occurrence of pregnancy on oral contraceptive in a 17-year-old female subject who was vaccinated with PRIORIX (GlaxoSmithKline), ENGERIX B adult and GARDASIL (non-GSK). Since April 2008, the subject was under YASMIN without forgetting to take the pill, without co-medication or episode of diarrhea or vomiting. On 23 March 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). On 27 March 2009, the subject had her last menstruation. On 30 March 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 10 April 2009 (estimated date of conception for a regular cycle), the subject was found to be pregnant. On 28 May 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 8 June 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). The regulatory authority reported that the events were clinically significant (or requiring intervention). The regulatory authority reported that the events were possibly related to vaccination with PRIORIX, ENGERIX B adult and GARDASIL and to YASMIN.


Changed on 2/14/2018

VAERS ID: 351587 Before After
VAERS Form:1
Age:17.0
Gender:Female
Location:Foreign
Vaccinated:2009-03-23
Onset:2009-04-10
Submitted:2009-07-16
Entered:2009-07-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (PRIORIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Pregnancy on oral contraceptive, Drug exposure during pregnancy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0583179A

Write-up: This case was reported by a foreign regulatory authority (# 2009-02622) and described the occurrence of pregnancy on oral contraceptive in a 17-year-old female subject who was vaccinated with PRIORIX (GlaxoSmithKline), ENGERIX B adult and GARDASIL (non-GSK). Since April 2008, the subject was under YASMIN without forgetting to take the pill, without co-medication or episode of diarrhea or vomiting. On 23 March 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). On 27 March 2009, the subject had her last menstruation. On 30 March 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 10 April 2009 (estimated date of conception for a regular cycle), the subject was found to be pregnant. On 28 May 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 8 June 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). The regulatory authority reported that the events were clinically significant (or requiring intervention). The regulatory authority reported that the events were possibly related to vaccination with PRIORIX, ENGERIX B adult and GARDASIL and to YASMIN.


Changed on 6/14/2018

VAERS ID: 351587 Before After
VAERS Form:1
Age:17.0
Gender:Female
Location:Foreign
Vaccinated:2009-03-23
Onset:2009-04-10
Submitted:2009-07-16
Entered:2009-07-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (PRIORIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Pregnancy on oral contraceptive, Drug exposure during pregnancy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0583179A

Write-up: This case was reported by a foreign regulatory authority (# 2009-02622) and described the occurrence of pregnancy on oral contraceptive in a 17-year-old female subject who was vaccinated with PRIORIX (GlaxoSmithKline), ENGERIX B adult and GARDASIL (non-GSK). Since April 2008, the subject was under YASMIN without forgetting to take the pill, without co-medication or episode of diarrhea or vomiting. On 23 March 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). On 27 March 2009, the subject had her last menstruation. On 30 March 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 10 April 2009 (estimated date of conception for a regular cycle), the subject was found to be pregnant. On 28 May 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 8 June 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). The regulatory authority reported that the events were clinically significant (or requiring intervention). The regulatory authority reported that the events were possibly related to vaccination with PRIORIX, ENGERIX B adult and GARDASIL and to YASMIN.


Changed on 8/14/2018

VAERS ID: 351587 Before After
VAERS Form:1
Age:17.0
Gender:Female
Location:Foreign
Vaccinated:2009-03-23
Onset:2009-04-10
Submitted:2009-07-16
Entered:2009-07-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (PRIORIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Pregnancy on oral contraceptive, Drug exposure during pregnancy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0583179A

Write-up: This case was reported by a foreign regulatory authority (# 2009-02622) and described the occurrence of pregnancy on oral contraceptive in a 17-year-old female subject who was vaccinated with PRIORIX (GlaxoSmithKline), ENGERIX B adult and GARDASIL (non-GSK). Since April 2008, the subject was under YASMIN without forgetting to take the pill, without co-medication or episode of diarrhea or vomiting. On 23 March 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). On 27 March 2009, the subject had her last menstruation. On 30 March 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 10 April 2009 (estimated date of conception for a regular cycle), the subject was found to be pregnant. On 28 May 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 8 June 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). The regulatory authority reported that the events were clinically significant (or requiring intervention). The regulatory authority reported that the events were possibly related to vaccination with PRIORIX, ENGERIX B adult and GARDASIL and to YASMIN.


Changed on 9/14/2018

VAERS ID: 351587 Before After
VAERS Form:1
Age:17.0
Gender:Female
Location:Foreign
Vaccinated:2009-03-23
Onset:2009-04-10
Submitted:2009-07-16
Entered:2009-07-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (PRIORIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Pregnancy on oral contraceptive, Drug exposure during pregnancy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0583179A

Write-up: This case was reported by a foreign regulatory authority (# 2009-02622) and described the occurrence of pregnancy on oral contraceptive in a 17-year-old female subject who was vaccinated with PRIORIX (GlaxoSmithKline), ENGERIX B adult and GARDASIL (non-GSK). Since April 2008, the subject was under YASMIN without forgetting to take the pill, without co-medication or episode of diarrhea or vomiting. On 23 March 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). On 27 March 2009, the subject had her last menstruation. On 30 March 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 10 April 2009 (estimated date of conception for a regular cycle), the subject was found to be pregnant. On 28 May 2009, the subject received unspecified dose of ENGERIX B adult (unknown route of administration, lot number not provided) and unspecified dose of GARDASIL (unknown route of administration). On 8 June 2009, the subject received unspecified dose of PRIORIX (unknown route of administration, lot number not provided). The regulatory authority reported that the events were clinically significant (or requiring intervention). The regulatory authority reported that the events were possibly related to vaccination with PRIORIX, ENGERIX B adult and GARDASIL and to YASMIN.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=351587&WAYBACKHISTORY=ON


Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166